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Abstract
VIM-producing Klebsiella pneumoniae (n = 21) isolated from ten Greek hospitals during 2003–2007 were characterized with multilocus
sequence typing (MLST), semi-automated repetitive sequence-based PCR (rep-PCR) (Diversilab), plasmid replicon typing, serotyping and
screening for multiple resistance determinants. The isolates were selected to represent different strain clusters (defined by >80% similarity)
according to pulsed-field gel electrophoresis. MLST identified three major clonal complexes (CCs); CC147 (n = 8), CC18 (n = 5) and
CC14 (n = 3). Plasmid replicon typing showed that IncA/C and/or IncFIIK replicons were detected among isolates in each of the major CCs.
Good concordance was observed between semi-automated-rep PCR genotyping and MLST.
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Klebsiella pneumoniae harbouring metallo-b–lactamases are a
serious threat to the carbapenem class of antimicrobials. Some
years after the first detection of VIM in Verona, Italy, in the
year 1999, the prevalence of VIM-producing K. pneumoniae
(VPKP) became widespread in some regions of Southern
Europe. VPKP has given rise to major problems both with
respect to infection control and treatment [1–4]. In most
cases, isolates harbouring this class of enzyme have been
isolated from hospitalized patients in intensive care units
(ICUs) [4]. Data are still largely lacking regarding the clonal
structure of strains disseminating VIM. Therefore, the objec-
tive of this study was to determine the clonal diversity of VPKP
isolated in various parts of Greece at the peak of the epidemic
of 2003–2006 by using multilocus sequence typing (MLST).
After the first report of VPKP in Greece in 2003 [1], all 40
hospitals participating in the Greek System for Surveillance of
Antimicrobial Resistance (www.mednet.gr/whonet) forwarded
all VPKP clinical isolates to the National School of Public
Health in Athens for further study. Isolates were from human
sources, mainly from blood, wound, urinary and respiratory
tract samples. Molecular fingerprints for all isolates were
prepared by pulsed-field gel electrophoresis (PFGE) with Xba1
restriction and analysed in GelCompar (Applied Maths,
SintMaartens-Latem, Belgium). Fingerprints were classified as
distinct when similarity was <80%.
The present study included 21 isolates representing impor-
tant and distinct PFGE-types. Eleven isolates (52.3%) were
derived from five different hospitals (I-V) located in Athens,
while the rest of the isolates were collected from another five
different hospitals (VI-X) belonging to four different Greek cities
(Table 1). A PCR-based serotyping method was conducted to
determine the capsular types K1, K2, K5, K20, K54 and K57, and
screening for the virulence genes allS, rmpA and wcaG was
performed by PCR amplification. [5], while PCR-based replicon
typing of plasmids was performed according to Carattoli et al.
[6]. MLST was performed by PCR amplification and sequencing
of seven conserved housekeeping genes (gapA, infB, mdh, pgi,
phoE, rpoB and tonB) (http://www.pasteur.fr/genopole/PF8/mlst/
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Kpneumoniae.htm). Based on allelic profiles, a graphical tool-
based minimal spanning tree (MST) built in Bionumerics 6.0
(Applied-Maths) was constructed. The genetic relatedness of
isolates was also evaluated with DiversiLab (DL), a semi-
automated repetitive-sequence-PCR (rep-PCR)-based micro-
bial typing system (bioMerieux, Marcy l’Etoile, France). Isolates
were assigned to the same DL type if they had >93% similarity
and  2 peak differences in the electropherogram overlay
analysis [7]. Additionally, PCR-based screening methods were
carried out to determine the concomitant carriage of extended-
spectrum, b-lactamase genes (blaCTX-M) [8], plasmid-mediated
quinolone resistance genes (qnrA, qnrB, qnrC, qnrS, aac-(6′)-lb-cr)
[9,10], 16S rRNA methylase genes (armA, rmtB, rmtD) [11] and
plasmid-mediated AmpC b-lactamase genes (CIT, MOX, FOX,
ACC, EBC and DHA) [12].
The population structure of 21 VPKP isolates is shown in
Fig. 1 with 11 sequence types (STs) classifiable. The most
frequently detected sequence type was ST147, with six repre-
sentative isolates. Additionally, two SLVs of this ST were
detected (ST675 and ST677),making the total numberof isolates
in clonal complex (CC) 147 8/21 (38%). Isolates belonging to
clonal lineage CC147 were detected in all regions except
Piraeus, and have also been described in previous strain imports
fromGreece to Scandinavia [13]. Another sequence type, ST17,
had three representative isolates, and together with its SLV
ST674 (n = 2), formed the second clonal complex, CC18. The
third clonal complex, CC14, was formed between ST14 (n = 2)
and ST627 (n = 1), comprising strains from Athens and Piraeus,
respectively. Capsular type K2 was detected in the two isolates
of ST14, as has also recently been reported for NDM-1-carrying
K. pneumoniaeof ST14 [7].Other detected sequence typeswere
ST36 (n = 2) and ST323 (n = 1). ST36 did not clusterwith any of
the clonal complexes, differing from isolates in CC18 by 3 alleles.
ST323 differed from CC18 isolates by only two alleles.
PCR-based replicon typing (PBRT) revealed that IncFIIK
occurred in the majority of the isolates (n = 15/21), followed
by IncA/C (n = 10/21). Isolates belonging to the major clonal
complexes or STs hosted both replicon IncFIIK and IncA/C,
whereas IncA/C plus IncN was hosted by a single isolate. The
IncA/C plasmid type is well known for its role in the
dissemination and wide transmission of both NDM-1 and
VIM globally [13,14], whereas IncFIIK has been responsible for
the acquisition and dispersion of KPC-2 and CTX-M-1
amongst K. pneumoniae in Greece [15]. One previous study
has shown that the linkage of VIM carbapenemase with
importation to Scandinavia from Greece has greatly been
facilitated by broad host-range IncA/C and IncN plasmids
hosted by sequence type ST36, ST147 and ST323 [13]. It
should be noted that the specific relationship between blaVIM
and plasmid replicons was not sought in this study.
The genetic relatedness among this entire collection of
isolates was also assessed by the DiversiLab microbial typing
system. The DiversiLab rep-PCR system grouped all the STs
into eight DL types (A-H) (Table 1). The DiversiLab system
assigned STs belonging to the major clonal lineages to the same
DL type, with the exception of one isolate of ST14 that was
assigned to a different DL type than the other ST14 isolates.
Moreover, STs that did not belong to any of the clonal
complexes were also unique according to the DiversiLab
system, as has previously been shown in NDM-1 producing
TABLE 1. Characteristics of 21 VIM-producing K. pneumoniae strains isolated from Greece
Strain Hospital Area Specimen ST CC
DL
type PBRT Serotypea
Virulence
gene CTX-M PMQRb 16Sc pAmpC
Isolation
year
VPKP194 I Athens Unknown 147 147 B ND - - - - - - -
VPKP203 II Athens Urine 147 147 B A/C - - - aac(6′)-Ib-cr - - 2006
VPKP213 V Athens Sputum 147 147 B ND - - - - - - 2005
VPKP842 VII Thessaloniki Wound 147 147 B ND - - - - - MOX 2007
VPKP18 IX Crete Wound 147 147 B FIIK - - - - - - 2005
VPKP33 IX Crete Urine 147 147 B FIIK - - - aac(6′)-Ib-cr - - 2005
VPKP267 VI Thessaloniki Blood 675 147 B ND - - - - - - 2006
VPKP754 X NW Greece Unknown 677 147 B A/C, FIIK - - - - - - 2007
VPKP205 II Athens Blood 17 18 F FIIK - - - aac(6′)-Ib-cr - - 2006
VPKP440 III Athens Blood 17 18 F FIIK - - - - - - 2006
VPKP309 VIII Piraeus Sputum 17 18 F FIIK - - - aac(6′)-Ib-cr - - 2006
VPKP284 VI Thessaloniki Blood 676 18 E A/C, FIIK - - - - - - 2006
VPKP307 VIII Piraeus Blood 676 18 E A/C, FIIK - - - aac(6′)-Ib-cr - MOX 2006
VPKP374 IV Athens Sputum 14 14 C A/C, FIIK K2 - - aac(6′)-Ib-cr - - 2006
VPKP430 III Athens Wound 14 14 D A/C, FIIK K2 - - aac(6′)-Ib-cr - - 2003
VPKP306 VIII Piraeus Catheter 627 14 C A/C, FIIK - - - - - - 2006
VPKP389 IV Athens Blood 36 36 A FIIK - - - - - - 2006
VPKP6 I Athens Unknown 36 36 A A/C, FIIK - - - qnrS - - 2005
VPKP220 V Athens Pus 706 - B FIIK - - - - - - 2006
VPKP229 V Athens Unknown 674 - G A/C, N - - - aac(6′)-Ib-cr - - 2006
VPKP83 X NW Greece Blood 323 26 H A/C - - - aac(6′)-Ib-cr - - 2005
ND, not detected.
aThe following serotypes were sought by PCR: K1, K2, K5, K20, K54 and K57.
bThe following genes encoding PMQR (plasmid-mediated quinolone resistance) were sought: qnrA, qnrB, qnrC, qnrS and aac (6′)-Ib-cr.
cThe following 16S rRNA methylases were screened for: armA, rmtA, rmtB and rmtD.
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isolates [7]. The concept of using DiversiLab as a proxy for
MLST could be valid also for VPKP according to these data, but
a larger investigation is warranted.
In conclusion, this study shows that a limited number of
clones were responsible for the dissemination of blaVIM during
the peak of the Greek epidemic. Several of these clones have
been shown to disseminate also other important resistance
determinants, and should be considered epidemic. Recent
studies from Greece have shown that some STs, including
ST147 and ST323, are also responsible for simultaneous
production of blaVIM and blaKPC [3].
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